88 MYLAN (Carbidopa and levodopa extended release 25 mg / 100 mg)

Pill imprint 88 MYLAN has been identified as Carbidopa and levodopa extended release 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of restless legs syndrome; parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 88 MYLAN

Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN Front
Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN Back
Carbidopa and levodopa extended release 25 mg / 100 mg 88 MYLAN
Carbidopa and levodopa extended release
Imprint:
88
MYLAN
Strength:
25 mg / 100 mg
Color:
Purple
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0088
Inactive Ingredients:
FD&C Blue No. 2
FD&C Red No. 40
hydroxypropyl cellulose
hypromelloses
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0978 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)